News – Page 1101 – Endpoints News

Novartis follows up on big CAR-T win by naming Vas Narasimhan as its new CEO

8 years ago

Biogen vet Alpna Seth jumps to George Scangos' biotech startup; Top FDA scientist makes a leap to PhRMA

8 years ago

Doctors Without Borders say FDA's PRV incentive is misused; Teva drug wins FDA OK on tardive dyskinesia

8 years ago

NEA-backed Nightstar Therapeutics sets sights on an $86M IPO to fund PhIII gene therapy study

8 years ago

Troubled Acorda hurries to bar the door against a takeover attempt

8 years ago

Neurotoxicity kills a CAR-T rival pushed by J&J, MacroGenics in $700M deal

8 years ago

The top 10 biopharma CROs in the world—mid-2017 edition

8 years ago

Feds scoop up a band of biotech insiders who allegedly bagged a windfall, and now criminal charges

8 years ago

Novartis, UCSF researchers urge FDA to clean up its messy adverse events database

8 years ago

UK government backs $189M effort to bolster life sci; Bayer files hemophilia drug; Akcea files volanesorsen NDA

8 years ago

SteadyMed shares slammed as FDA tosses its NDA for PAH drug-device

8 years ago

Daiichi Sankyo punts $650M collaboration pact as Charleston Labs preps a comeback attempt on spurned pain drug

8 years ago

Top FDA trial expert Richard Moscicki jumps to a senior post at PhRMA

8 years ago

Incyte's good week continues with an encouraging update on IDO1 star epacadostat

8 years ago

Daiichi Sankyo douses a puzzling report about an AstraZeneca buyout offer

8 years ago

FDA ushers in a new era in cancer treatment with 'historic' CAR-T approval for Novartis

8 years ago

Ionis earns $40M on Spinraza advance; Five Prime axes Inhibrx deal

8 years ago

Star team quietly raises $21M to launch the latest immuno-oncology startup Torque

8 years ago

BioMarin says the FDA game clock now ticking on their blockbuster hopeful pegvaliase

8 years ago

Otonomy staggered by an ugly PhIII failure for lead pipeline drug

8 years ago

In stunning about-face, FDA invites Eli Lilly to quickly refile blockbuster hopeful baricitinib

8 years ago

Medicines Co scores FDA OK for new antibiotic, now up on the auction block

8 years ago

A nonprofit group’s Chagas drug beat out Martin Shkreli's old rival to FDA OK, valuable PRV

8 years ago

Celgene antes up $195M more to stay close to Forma, adding neurodegeneration focus

8 years ago

First page Previous page 1098 1099 110011011102 1103 1104 Next page Last page